FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2258010387> ?p ?o ?g. }

• W2258010387 endingPage "110" @default.
• W2258010387 startingPage "106" @default.
• W2258010387 abstract "A high prevalence (52%) of hyperhomocysteinemia is observed in Crohn disease (CD), however it is not well documented in ulcerative colitis (UC). Furthermore, in the different works studying hyperhomocysteinemia the associated factors are different.Prospective evaluation of hyperhomocysteinemia in inflammatory bowel disease (IBD) patients, of the risk factors and the determination of a potential risk of colorectal carcinoma in case of hyperhomocysteinemia.IBD patients followed in our department were prospectively recruited between November 2003-September 2004. To be included patients should have passed a coloscopy in the two years. Patients with kidney failure or drugs supposed, to interfere with homocystéine metabolism (folates, vitamin B12, methotrexate) were excluded from the study. The following parameters were analysed: age, sex, clinical activity indexes (CDAI for Crohn disease and CAI for ulcerative colitis), length-extent and type of the disease (CD or UC), smoking, plasma homocystein concentration, folates and vitamin B12.Eighty-one patients (60 CD, 21 UC, mean age 43.8 +/- 17.3) were included, 30 had an active disease at inclusion and 16 were smokers. The prevalence of high homocystein concentration was 55.6%. In univariate analysis a low rate of folates was the only risk factor for a high homocystein concentration (74 vs. 52.8%; P = 0.018). Smoking was almost an associated factor. In multivariate analysis, a low rate of folate was the only risk factor of hyperhomocysteinemia, OR = 3.59 [1.27-10.17]. Five endoscopic lesions considered as precancerous were described; these patients had all a hyperhomocysteinemia.The prevalence of hyperhomocysteinemia is high in UC and in CD. A low folate rate is the only risk factor observed in our study. There is a possible link between colorectal cancer and hyperhomocysteinemia. A high Plasma homocystein concentration must be search in inflammatory bowel disease patients and a substitutive treatment of folates and vitamin B12 is necessary in case of hyperhomocysteinemia." @default.
• W2258010387 created "2016-06-24" @default.
• W2258010387 creator A5002940709 @default.
• W2258010387 creator A5005875707 @default.
• W2258010387 creator A5008687957 @default.
• W2258010387 creator A5015116765 @default.
• W2258010387 creator A5051809824 @default.
• W2258010387 creator A5054195758 @default.
• W2258010387 creator A5068230760 @default.
• W2258010387 creator A5080350003 @default.
• W2258010387 creator A5086543019 @default.
• W2258010387 date "2006-02-01" @default.
• W2258010387 modified "2023-10-18" @default.
• W2258010387 title "Hyperhomocystéinémie et facteurs associés au cours des MICI : étude prospective chez 81 patients" @default.
• W2258010387 cites W112879263 @default.
• W2258010387 cites W1546655977 @default.
• W2258010387 cites W1973810214 @default.
• W2258010387 cites W1977879763 @default.
• W2258010387 cites W1978419388 @default.
• W2258010387 cites W1984114882 @default.
• W2258010387 cites W2010868528 @default.
• W2258010387 cites W2027083846 @default.
• W2258010387 cites W2036312648 @default.
• W2258010387 cites W2037211768 @default.
• W2258010387 cites W2042507296 @default.
• W2258010387 cites W2049418341 @default.
• W2258010387 cites W2061183782 @default.
• W2258010387 cites W2093110099 @default.
• W2258010387 cites W2104080712 @default.
• W2258010387 cites W2107649737 @default.
• W2258010387 cites W2121650731 @default.
• W2258010387 cites W2123456725 @default.
• W2258010387 cites W2141804997 @default.
• W2258010387 cites W2156749160 @default.
• W2258010387 cites W2165715420 @default.
• W2258010387 cites W2166644444 @default.
• W2258010387 cites W2188742919 @default.
• W2258010387 cites W2323783182 @default.
• W2258010387 cites W2340680662 @default.
• W2258010387 cites W3149527659 @default.
• W2258010387 cites W2337283028 @default.
• W2258010387 doi "https://doi.org/10.1016/j.revmed.2005.11.005" @default.
• W2258010387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16376461" @default.
• W2258010387 hasPublicationYear "2006" @default.
• W2258010387 type Work @default.
• W2258010387 sameAs 2258010387 @default.
• W2258010387 citedByCount "16" @default.
• W2258010387 countsByYear W22580103872012 @default.
• W2258010387 countsByYear W22580103872013 @default.
• W2258010387 countsByYear W22580103872014 @default.
• W2258010387 countsByYear W22580103872016 @default.
• W2258010387 crossrefType "journal-article" @default.
• W2258010387 hasAuthorship W2258010387A5002940709 @default.
• W2258010387 hasAuthorship W2258010387A5005875707 @default.
• W2258010387 hasAuthorship W2258010387A5008687957 @default.
• W2258010387 hasAuthorship W2258010387A5015116765 @default.
• W2258010387 hasAuthorship W2258010387A5051809824 @default.
• W2258010387 hasAuthorship W2258010387A5054195758 @default.
• W2258010387 hasAuthorship W2258010387A5068230760 @default.
• W2258010387 hasAuthorship W2258010387A5080350003 @default.
• W2258010387 hasAuthorship W2258010387A5086543019 @default.
• W2258010387 hasConcept C126322002 @default.
• W2258010387 hasConcept C144301174 @default.
• W2258010387 hasConcept C188816634 @default.
• W2258010387 hasConcept C2776523773 @default.
• W2258010387 hasConcept C2778260677 @default.
• W2258010387 hasConcept C2779134260 @default.
• W2258010387 hasConcept C2779280984 @default.
• W2258010387 hasConcept C2779750884 @default.
• W2258010387 hasConcept C2780479503 @default.
• W2258010387 hasConcept C38180746 @default.
• W2258010387 hasConcept C50440223 @default.
• W2258010387 hasConcept C71924100 @default.
• W2258010387 hasConcept C90924648 @default.
• W2258010387 hasConceptScore W2258010387C126322002 @default.
• W2258010387 hasConceptScore W2258010387C144301174 @default.
• W2258010387 hasConceptScore W2258010387C188816634 @default.
• W2258010387 hasConceptScore W2258010387C2776523773 @default.
• W2258010387 hasConceptScore W2258010387C2778260677 @default.
• W2258010387 hasConceptScore W2258010387C2779134260 @default.
• W2258010387 hasConceptScore W2258010387C2779280984 @default.
• W2258010387 hasConceptScore W2258010387C2779750884 @default.
• W2258010387 hasConceptScore W2258010387C2780479503 @default.
• W2258010387 hasConceptScore W2258010387C38180746 @default.
• W2258010387 hasConceptScore W2258010387C50440223 @default.
• W2258010387 hasConceptScore W2258010387C71924100 @default.
• W2258010387 hasConceptScore W2258010387C90924648 @default.
• W2258010387 hasIssue "2" @default.
• W2258010387 hasLocation W22580103871 @default.
• W2258010387 hasLocation W22580103872 @default.
• W2258010387 hasOpenAccess W2258010387 @default.
• W2258010387 hasPrimaryLocation W22580103871 @default.
• W2258010387 hasRelatedWork W1576589857 @default.
• W2258010387 hasRelatedWork W2055483484 @default.
• W2258010387 hasRelatedWork W2106015740 @default.
• W2258010387 hasRelatedWork W2375484873 @default.
• W2258010387 hasRelatedWork W2912638322 @default.
• W2258010387 hasRelatedWork W3022383156 @default.

• next